News
AFCR SUPPORTS various types of cancer and stages of research including basic, translational and clinical.
As we celebrate this remarkable 20-year milestone, we honor the dedication of scientists, donors, and partners who have made these achievements possible.
The future holds even greater promise as…
The Asian Fund for Cancer Research (AFCR) is committed to supporting groundbreaking cancer research and promoting accurate, science-based health information. In light of recent public discussions and a fact-check article published by the Taiwan FactCheck Center, we wish to clarify AFCR’s position…
This year marks a monumental milestone—the 20th anniversary of the Asian Fund for Cancer Research (AFCR). For two decades, your unwavering support has fueled groundbreaking discoveries, advanced life-saving treatments, and brought hope to millions of individuals and families affected by cancer.
Today, we…
A Breakthrough Approach to “Undruggable” Targets
THE CHALLENGE: Undruggable Targets In Cancer
Many cancer-driving proteins remain out of reach for current treatments. These include transcription factors, RNA-binding proteins, and other intracellular regulators that lack suitable binding sites for traditional drugs. Biologic therapies,…
Position Overview:
The Director of Marketing and Business Development at the Asian Fund for Cancer Research (AFCR) is responsible for driving the foundation’s growth in Hong Kong and the Asia-Pacific region by developing and executing comprehensive marketing strategies, managing strategic partnerships, and…
Celiac disease is an immune reaction triggered by consuming gluten, a protein found in wheat, barley, and rye. Research indicates that individuals with celiac disease have a higher risk of developing three types of cancer.
WHO IS AFFECTED BY CELIAC DISEASE?
Celiac disease…
We are proud to recognize this year’s outstanding early-career Chinese cancer researchers for their remarkable contributions to advancing cancer research and drug development.
Since 2010, the Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association have jointly presented the USCACA-AFCR…
NOTABLE RESEARCH HIGHLIGHTS
AFCR-supported scientists have made remarkable advances in the fight against cancer. Here are some notable research highlights in 2024 supported by your generous donations.
First-in Class Molecular Glue Degraders
Dr. Lily Zou’s research is at the forefront of developing a novel…
The 2024 Give to Cure Cancer Year-End Appeal is now underway. This is a chance to make this year’s campaign the most successful ever.
We are proud to report...
With support from loyal donors, excellent progress has been made in these AFCR-funded projects in…
Cancer patients and survivors often have fears related to their health, such as recurrence or pending treatment. But the sources of stress and anxiety don’t stop there. Cancer can ignite concerns about family, finances, changes in body image and the challenges of…
The 2024 NFCR Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship, co-hosted by the National Foundation for Cancer Research (NFCR), AIM-HI Accelerator Fund (AIM-HI), and Asian Fund for Cancer Research (AFCR) will be held on October 18th at the National…
AFCR will celebrate its 20 Year Anniversary in 2025. In those 20 years, AFCR has been focused on funding cancer research, especially those cancers prevalent in Asian populations. Here is a snapshot of the research fields we will fund during 2024-2025.
CHANGING THE…
Hong Kong (5 September 2024) – The Asian Fund for Cancer Research Limited (AFCR) is pleased to announce the winners of the 2024 BRACE Award Venture Competition: the First Prize goes to Concarlo Therapeutics, led by Founder and CEO Stacy Blain, Ph.D.,…
The U.S. Chinese Anti-Cancer Association (USCACA) and AFCR are pleased to invite nominations for the USCACA‐AFCR 2024 Young Investigator Awards.
The Awards will recognize 3 to 5 junior Chinese investigators on the basis of significant contributions in Translational or Clinical Cancer Research.
Candidacy…
On 14 June 2024, AFCR is launching our inaugural Day of Giving. This special event aims to spotlight the critical "unmet needs in cancer research and patient care." By generously supporting AFCR, you empower us to drive groundbreaking discoveries in the fight…